Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Item
http://www.wikidata.org/entity/Q39275045
Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in CancerA Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC.Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cellsDevelopment of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.Profile of panobinostat and its potential for treatment in solid tumors: an update.Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma.PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy
P2860

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Item
http://www.wikidata.org/entity/Q39275045
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Low dose histone deacetylase i ...... via PI3K/Akt pathway in vitro.
@en
Low dose histone deacetylase i ...... via PI3K/Akt pathway in vitro.
@nl
type
label
Low dose histone deacetylase i ...... via PI3K/Akt pathway in vitro.
@en
Low dose histone deacetylase i ...... via PI3K/Akt pathway in vitro.
@nl
prefLabel
Low dose histone deacetylase i ...... via PI3K/Akt pathway in vitro.
@en
Low dose histone deacetylase i ...... via PI3K/Akt pathway in vitro.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Low dose histone deacetylase i ...... via PI3K/Akt pathway in vitro.
@en
P2093
P304
P31
P356
10.1016/J.CANLET.2012.08.035
P407
P433
P478
P50
P577
P5875
P698
P921